OBJECTIVES: I. Evaluate the efficacy and tolerability of fructose administered every 6 hours
for up to 72 hours to patients in active sickle cell crisis.
II. Obtain tolerability information in selected patients treated with fructose for more than
72 hours.
Phase:
N/A
Details
Lead Sponsor:
National Center for Research Resources (NCRR)
Collaborators:
Rehabilitation Institute of Chicago Shirley Ryan AbilityLab